Departments of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Int J Urol. 2020 Aug;27(8):649-654. doi: 10.1111/iju.14263. Epub 2020 May 25.
To investigate the effect of frailty on the type of urinary diversion after radical cystectomy in patients with muscle-invasive bladder cancer.
Between January 2014 and January 2020, we prospectively evaluated frailty in 88 patients with localized muscle-invasive bladder cancer, who had received radical cystectomy and urinary diversion. The selection of the type of urinary diversion was determined by the operating surgeon based on performance status, comorbidities, tumor status and the patient's preference. The frailty evaluation included the Fried phenotype criteria, the modified frailty index and the frailty discriminant score. We investigated the association between frailty and type of urinary diversion, the effect of frailty on postoperative complications and the effect of frailty on overall survival.
The median age of the selected participants was 68 years. The number of patients with an orthotopic neobladder and any postoperative complications was 54 (61%) and 46 (52%), respectively. Of the frailty assessment tools that were used, Fried phenotype criteria and frailty discriminant score were significantly associated with the selection of non-orthotopic neobladder urinary diversion. Occurrences of postoperative complications in participants were significantly associated with modified frailty index, but not with Fried phenotype criteria and frailty discriminant score. Multivariate Cox regression analysis showed that a higher frailty discriminant score was significantly associated with poor overall survival, whereas higher Fried phenotype criteria and modified frailty index were not.
Frailty is significantly associated with the type of urinary diversion, and it should be considered for the selection of urinary diversion in muscle-invasive bladder cancer patients undergoing radical cystectomy.
探讨衰弱对肌层浸润性膀胱癌患者根治性膀胱切除术后尿流改道类型的影响。
2014 年 1 月至 2020 年 1 月,我们前瞻性评估了 88 例接受根治性膀胱切除术和尿流改道的局限性肌层浸润性膀胱癌患者的衰弱情况。尿流改道类型的选择由手术医生根据体能状态、合并症、肿瘤状况和患者偏好决定。衰弱评估包括 Fried 表型标准、改良衰弱指数和衰弱判别评分。我们调查了衰弱与尿流改道类型之间的关系、衰弱对术后并发症的影响以及衰弱对总生存的影响。
入选患者的中位年龄为 68 岁。54 例(61%)患者采用了原位新膀胱,46 例(52%)患者发生了任何术后并发症。在使用的衰弱评估工具中,Fried 表型标准和衰弱判别评分与非原位新膀胱尿流改道的选择显著相关。参与者术后并发症的发生与改良衰弱指数显著相关,而与 Fried 表型标准和衰弱判别评分无关。多变量 Cox 回归分析显示,较高的衰弱判别评分与总生存不良显著相关,而较高的 Fried 表型标准和改良衰弱指数则与总生存不良无关。
衰弱与尿流改道类型显著相关,在为接受根治性膀胱切除术的肌层浸润性膀胱癌患者选择尿流改道时应考虑衰弱因素。